CBY1P1

Across TCGA pan-cancer cohorts, CBY1P1 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated CBY1P1 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher CBY1P1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated CBY1P1 expression acts as an unfavorable survival marker, although some lineages such as OV and UCEC show a favorable association.

OV, KICH, and KIRC are the cancer types where CBY1P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	III,IV	0.597	0.147	.006	96	view →
KICH	OS	Tertile	II,III,IV	0.159	0.844	<.001	81	view →
KIRC	OS	Tertile	All	0.462	0.652	.002	54	view →
BRCA	OS	Tertile	IV	0.233	0.755	.038	36	view →
CHOL	OS	Tertile	All	0.154	0.793	.004	27	view →
PAAD	DFS	Tertile	All	0.198	0.515	.014	18	view →
UCEC	OS	Tertile	II,III,IV	0.925	0.322	.035	18	view →
READ	OS	Tertile	IV	0.077	1.000	.014	9	view →
LIHC	OS	Tertile	All	0.169	0.669	.032	9	view →
COAD	DFS	Tertile	II,III,IV	0.609	0.761	.048	3	view →
LUSC	OS	Tertile	All	0.244	0.524	.042	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

CBY1P1–OV (DFS)

Open the OV breakdown →